Application 018868
- Type
- NDA
- Sponsor
- KALAPHARM
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | FUROSEMIDE | FUROSEMIDE | TABLET;ORAL | 20MG | No | No |
| 002 | FUROSEMIDE | FUROSEMIDE | TABLET;ORAL | 40MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N018868-001 | FUROSEMIDE | FUROSEMIDE | 20MG | TABLET / ORAL | 1983-06-28 | ||
| N018868-002 | FUROSEMIDE | FUROSEMIDE | 40MG | TABLET / ORAL | 1983-06-28 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N018868-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1983-06-28 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N018868-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1983-06-28 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | N018868-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1983-06-28 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N018868-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1983-06-28 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N018868-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1983-06-28 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N018868-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1983-06-28 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N018868-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1983-06-28 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N018868-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1983-06-28 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N018868-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1983-06-28 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N018868-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1983-06-28 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N018868-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1983-06-28 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N018868-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1983-06-28 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N018868-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1983-06-28 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N018868-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1983-06-28 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N018868-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1983-06-28 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N018868-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1983-06-28 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N018868-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1983-06-28 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N018868-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1983-06-28 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N018868-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1983-06-28 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N018868-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1983-06-28 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N018868-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1983-06-28 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N018868-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1983-06-28 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | N018868-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1983-06-28 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | N018868-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1983-06-28 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N018868-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1983-06-28 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N018868-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1983-06-28 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N018868-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1983-06-28 | 301d65b070ca… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N018868-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1983-06-28 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N018868-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1983-06-28 | 1e350fbaab3a… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N018868-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1983-06-28 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | N018868-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1983-06-28 | 8072bd15b7f6… | ||
| 2024-05-31 18:47 UTC | 2024-05 | N018868-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1983-06-28 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N018868-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1983-06-28 | 5c6f7cd8ea54… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N018868-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1983-06-28 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | N018868-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1983-06-28 | 5d02ea3f76ae… | ||
| 2022-04-08 23:34 UTC | 2022-04 | N018868-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1983-06-28 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | N018868-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1983-06-28 | 4b0b4de00fa7… | ||
| 2022-04-04 05:41 UTC | 2022-04 | N018868-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1983-06-28 | 4b0b4de00fa7… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N018868-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1983-06-28 | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N018868-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1983-06-28 | 74a2ff9319b5… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Furosemide | FUROSEMIDE | A-S Medication Solutions | 60cf5e60-9a7a-42c2-95b5-016f7a68ffc4 | 2023-12-18 | Warnings, Adverse reactions | Furosemide FUROSEMIDE |
| Furosemide | FUROSEMIDE | Medical Purchasing Solutions, LLC | 0a105e0b-b5cc-d929-e063-6294a90a80af | 2023-11-13 | Boxed warning, Warnings, Adverse reactions | Furosemide FUROSEMIDE |
| Furosemide | FUROSEMIDE | A-S Medication Solutions | a2e46e16-4adf-4599-b69d-a6f6f891ba75 | 2023-10-31 | Warnings, Adverse reactions | Furosemide FUROSEMIDE |
| Furosemide | FUROSEMIDE | Bryant Ranch Prepack | 020bc039-9e99-4895-96f8-0c6a556d3e67 | 2023-10-04 | Warnings, Adverse reactions | Furosemide FUROSEMIDE |
| FUROSEMIDE | FUROSEMIDE | Medical Purchasing Solutions, LLC | 6a2235e8-d488-2d43-e053-2991aa0aa485 | 2023-05-30 | Boxed warning, Warnings, Adverse reactions | FUROSEMIDE FUROSEMIDE |
| FUROSEMIDE | FUROSEMIDE | Medical Purchasing Solutions, LLC | 6947af02-f50b-7f9c-e053-2a91aa0a45cd | 2023-05-22 | Boxed warning, Warnings, Adverse reactions | FUROSEMIDE FUROSEMIDE |
| Furosemide | FUROSEMIDE | Medical Purchasing Solutions, LLC | bbf03f9a-ae33-8da1-e053-2a95a90a3bdb | 2023-05-08 | Boxed warning, Warnings, Adverse reactions | Furosemide FUROSEMIDE |
| Furosemide | FUROSEMIDE | Medical Purchasing Solutions, LLC | d8a064cc-c741-8b80-e053-2a95a90a364c | 2023-05-03 | Warnings, Adverse reactions | Furosemide FUROSEMIDE |
| Furosemide | FUROSEMIDE | Medical Purchasing Solutions, LLC | ea4ead7c-c798-2d85-e053-2a95a90ab0b0 | 2023-04-24 | Boxed warning, Warnings, Adverse reactions | Furosemide FUROSEMIDE |
| Furosemide | FUROSEMIDE | A-S Medication Solutions | 25171259-dcf1-4984-9581-cd69dee8dffb | 2023-04-19 | Warnings, Adverse reactions | Furosemide FUROSEMIDE |
| Furosemide | FUROSEMIDE | Calvin Scott & Co., Inc. | 43be0231-0d88-4a21-b2ab-793155cbddb2 | 2023-03-23 | Warnings, Adverse reactions | Furosemide FUROSEMIDE |
| Furosemide | FUROSEMIDE | Bryant Ranch Prepack | 01a5f094-b473-4e46-9e61-69d5ec6dd766 | 2023-03-01 | Warnings, Adverse reactions | Furosemide FUROSEMIDE |
| Furosemide | FUROSEMIDE | Bryant Ranch Prepack | 6820724c-1ca5-451c-9d2b-2d38e60036f5 | 2023-03-01 | Warnings, Adverse reactions | Furosemide FUROSEMIDE |
| Furosemide | FUROSEMIDE | Bryant Ranch Prepack | 440aaaed-47df-4bb5-8b41-2c8056893679 | 2023-03-01 | Warnings, Adverse reactions | Furosemide FUROSEMIDE |
| Furosemide | FUROSEMIDE | Bryant Ranch Prepack | 15ae6f44-88dd-4455-b1f7-4718c91e7b66 | 2023-03-01 | Warnings, Adverse reactions | Furosemide FUROSEMIDE |
| Furosemide | FUROSEMIDE | Bryant Ranch Prepack | 3ad12e70-3c2e-44af-bb6b-5762d181c76b | 2023-03-01 | Warnings, Adverse reactions | Furosemide FUROSEMIDE |
| Furosemide | FUROSEMIDE | A-S Medication Solutions | 52f0c9d5-396f-4033-abe8-145eec3e6983 | 2023-02-06 | Warnings, Adverse reactions | Furosemide FUROSEMIDE |
| Furosemide | FUROSEMIDE | Lifestar Pharma LLC | 92f3ab5d-361c-4e12-bb50-fd4a9f195a8f | 2022-12-22 | Warnings, Adverse reactions | Furosemide FUROSEMIDE |
| Furosemide | FUROSEMIDE | Proficient Rx LP | 595ddaf2-c2cb-44a4-a46c-53bcfe6bd752 | 2022-12-01 | Warnings, Adverse reactions | Furosemide FUROSEMIDE |
| Furosemide | FUROSEMIDE | Sagent Pharmaceuticals | d63c1277-dd7e-4d21-9e80-68143f55e2dc | 2022-11-29 | Boxed warning, Warnings, Adverse reactions | Furosemide FUROSEMIDE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.